HONG KONG — Biotech startup Prenetics, a COVID-19 test provider that helped soccer’s Premier League resume matches, is set to go public Wednesday on the Nasdaq, making it Hong Kong’s first unicorn to list.
Read more: https://asia.nikkei.com/Business/Health-Care/Hong-Kong-biotech-Prenetics-rides-COVID-wave-to-Nasdaq